Omega-3 Index

← Back to Lab Reference Library

Category: Inflammation & Cardiovascular  |  Also known as: EPA + DHA RBC Test, O3I  |  Sample: Whole blood (fasting not required)

1. What This Test Measures

The Omega-3 Index measures the percentage of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) found in red blood cell (RBC) membranes, expressed as a percentage of total fatty acids. Because red blood cells live approximately 120 days, the Omega-3 Index reflects your average omega-3 status over the preceding 3 to 4 months, making it a far more stable and reliable measure than a single serum omega-3 level.

EPA and DHA are long-chain omega-3 fatty acids found primarily in fatty fish, seafood, and fish oil supplements. They are structurally incorporated into every cell membrane in the body, where they profoundly influence membrane fluidity, receptor function, inflammatory signaling, and cellular communication. The higher the Omega-3 Index, the more EPA and DHA are present in membranes throughout the body, reducing inflammatory tone and improving cellular function across multiple organ systems.

The test was developed and validated by Dr. William Harris, one of the world's leading omega-3 researchers, and is now considered one of the most clinically important cardiovascular and inflammatory biomarkers in functional and preventive medicine.

2. Why This Test Matters

The Omega-3 Index has been validated across hundreds of peer-reviewed studies as an independent predictor of cardiovascular risk, cognitive function, inflammatory burden, and all-cause mortality.

• Cardiovascular disease: An Omega-3 Index below 4% is associated with a dramatically elevated risk of sudden cardiac death. Research by Harris and colleagues demonstrated a nearly 10-fold higher risk compared to individuals above 8%. The REDUCE-IT trial demonstrated that high-dose EPA supplementation significantly reduced major cardiovascular events in high-risk patients with elevated triglycerides.
• Heart rhythm: Higher omega-3 index levels are associated with reduced risk of atrial fibrillation and ventricular arrhythmias. EPA and DHA stabilize cardiac cell membranes and reduce electrical instability.
• Cognitive health and dementia: DHA is the dominant structural fatty acid in neural cell membranes. Low Omega-3 Index is consistently associated with accelerated brain atrophy, cognitive decline, and increased Alzheimer's disease risk.
• Depression and mood: EPA in particular has robust evidence as an antidepressant. Low omega-3 index is associated with higher rates of major depression, postpartum depression, and bipolar disorder.
• Systemic inflammation: EPA and DHA reduce production of pro-inflammatory eicosanoids, cytokines, and adhesion molecules. Raising the Omega-3 Index directly lowers hs-CRP, IL-6, and other inflammatory markers.
• Metabolic health: Higher omega-3 status improves insulin sensitivity, reduces triglycerides, and modestly raises HDL, all relevant to cardiometabolic risk.
• Pregnancy and fetal development: DHA is critical for fetal brain and retinal development. Low omega-3 status during pregnancy is associated with preterm birth and impaired neurodevelopmental outcomes.
• Longevity: Higher Omega-3 Index is independently associated with longer telomere length and reduced all-cause mortality in prospective studies.

3. Standard Lab Reference Range

Omega-3 Index Level	Conventional Risk Category
Below 4%	High cardiovascular risk zone
4 to 8%	Intermediate risk zone; below optimal
Above 8%	Lower cardiovascular risk zone

The majority of Americans have an Omega-3 Index between 4% and 6%, the intermediate risk zone, due to low fish consumption and high omega-6 dietary intake from seed oils and processed foods.

4. Optimal Functional Medicine Range

Omega-3 Index	Functional Interpretation
8 to 12%	Optimal: strong cardiovascular and anti-inflammatory protection
6 to 8%	Borderline: below optimal; supplementation indicated
4 to 6%	Low: where most Americans fall; meaningful cardiovascular risk
Below 4%	Deficient: high cardiovascular risk zone; aggressive repletion indicated

Traditional Japanese populations, among the world's lowest cardiovascular mortality rates, typically have Omega-3 Index values of 8 to 11%, driven by high fish consumption. Japanese Americans who adopt a Western diet see their index fall to 4 to 6% within one generation.

5. Symptoms Associated With Abnormal Levels

6. What Causes a Low Omega-3 Index

• Low fish and seafood consumption: the primary dietary source of EPA and DHA; the standard American diet is dramatically deficient
• High omega-6 seed oil intake: corn, soybean, sunflower, and safflower oils compete with omega-3 for incorporation into cell membranes and for enzymatic conversion pathways
• No fish oil supplementation, or use of low-quality supplements with inadequate EPA and DHA content
• Poor supplement absorption: fish oil taken without fat-containing meals absorbs poorly; triglyceride form absorbs better than ethyl ester form
• Genetic variation in FADS genes: impairs conversion of plant omega-3 (ALA) to EPA and DHA; common in populations of European descent
• Metabolic syndrome and insulin resistance: impairs fatty acid metabolism and omega-3 incorporation into membranes
• Aging: reduced enzyme efficiency for omega-3 metabolism
• Smoking: accelerates omega-3 oxidation and depletes tissue stores
• Vegetarian or vegan diet without algae-based DHA supplementation: plant sources provide only ALA, which converts to EPA and DHA at very low efficiency (below 5 to 10%)

7. How to Improve This Marker

8. Related Lab Tests

The Omega-3 Index is most informative when interpreted alongside these related markers:

9. When Testing Is Recommended

• Cardiovascular disease risk assessment, especially when triglycerides are elevated or HDL is low
• Any individual consuming a Western diet with low or no regular fish intake
• Depression, anxiety, cognitive concerns, or poor mood stability
• Inflammatory conditions: autoimmune disease, IBD, joint pain, inflammatory skin conditions
• Pregnancy planning or during pregnancy; DHA is critical for fetal neurodevelopment
• Athletes and individuals with high physical stress; omega-3 status significantly impacts recovery
• Monitoring response to omega-3 supplementation; retest at 3 to 4 months to confirm tissue-level response
• Any individual over 40 as part of comprehensive preventive cardiovascular assessment
• Vegetarians and vegans; high risk of deficiency without algae-based DHA supplementation

10. Clinical Perspective

11. Frequently Asked Questions